Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.

[1]  J. Ludwig,et al.  Hepatic steatosis as a potential risk factor for major hepatic resection , 1998, Journal of Gastrointestinal Surgery.

[2]  K. Sung,et al.  Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  Shi-yao Chen,et al.  Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.

[4]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[5]  M. Manos,et al.  Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.

[6]  A. Sanyal,et al.  The histologic spectrum of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[7]  L. Bolondi,et al.  Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance , 2004, Gut.

[8]  S. Jang,et al.  The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  C. Rosen,et al.  Evaluation of the donor liver for living donor liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[11]  S. Strasser,et al.  Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[13]  C. Ryan,et al.  One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[15]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[16]  P. Giral,et al.  Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.

[17]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[18]  D. Allison,et al.  Larger amounts of visceral adipose tissue in Asian Americans. , 2001, Obesity research.

[19]  M. Graif,et al.  Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. , 2000, Investigative radiology.

[20]  R. Fisher,et al.  Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. , 2000, Transplantation.

[21]  G. Brandi,et al.  Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.

[22]  L. Castéra,et al.  Pain experienced during percutaneous liver biopsy , 1999, Hepatology.

[23]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[24]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[25]  S. Thung,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Liver Pathology and the Metabolic Syndrome X in , 2022 .

[26]  K. Batts,et al.  Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.

[27]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.

[28]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.

[29]  S Burastero,et al.  Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. , 1994, The American journal of clinical nutrition.

[30]  F. Al-Mulhim,et al.  Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. , 1992, The British journal of radiology.

[31]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[32]  K. Ishak,et al.  Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. , 1988, Gastroenterology.

[33]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.